Detalhe da pesquisa
1.
EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells.
Int J Mol Sci
; 23(3)2022 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35162973
2.
DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.
J Pathol
; 245(4): 387-398, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29570800
3.
SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.
Mol Cancer
; 16(1): 1, 2017 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28093071
4.
Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.
Int J Cancer
; 137(6): 1330-40, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25735931
5.
Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma.
Transl Res
; 271: 40-51, 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38734064
6.
DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma.
Target Oncol
; 19(2): 263-275, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38401029
7.
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.
Clin Cancer Res
; 29(16): 3225-3236, 2023 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37036472
8.
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis.
Nat Cell Biol
; 25(10): 1506-1519, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37783795
9.
MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice.
Cancers (Basel)
; 14(3)2022 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35159020
10.
DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case-Control Study.
Front Oncol
; 12: 811729, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35356207
11.
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma.
J Immunother Cancer
; 10(3)2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35338086
12.
Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model.
Transl Oncol
; 19: 101378, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35259675
13.
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns.
Clin Cancer Res
; 28(20): 4565-4573, 2022 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35998208
14.
Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer.
Transl Res
; 230: 21-33, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33197651
15.
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
J Immunother Cancer
; 9(3)2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33762319
16.
Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines.
Sci Rep
; 10(1): 959, 2020 01 22.
Artigo
Inglês
| MEDLINE | ID: mdl-31969600
17.
Synthetic lethality guiding selection of drug combinations in ovarian cancer.
PLoS One
; 14(1): e0210859, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30682083
18.
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast.
Oncotarget
; 9(91): 36379-36391, 2018 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-30555636
19.
HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.
Mol Cancer Res
; 13(3): 556-64, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25349289
20.
EVI1 promotes tumor growth via transcriptional repression of MS4A3.
J Hematol Oncol
; 8: 28, 2015 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25886616